Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Iconix Pharmaceuticals, Inc. is pioneering the new field of chemogenomics, the integration of chemistry and genomics to profile drug candidates. Iconix’s chemogenomic capabilities enable pharmaceutical companies to increase the odds of advancing the right compounds to the clinic, reducing attrition rates and the costs of drug discovery. Iconix provides reference systems and know-how to predict toxic liabilities, side effects and mechanisms of drug candidates. The company has collaborations with Bristol Myers Squibb, Abbott Laboratories, ICOS, Schering-Plough (NYSE: SGP), AstraZeneca, Taisho Pharmaceutical Co., Ltd., Eisai Co., Ltd. and other leading companies. Iconix also provides research, training and support to the ( www.iconixpharm.com )
Iconix Pharmaceuticals , Inc.
325 East Middlefield Road
Mountain View, California 94043
USA
Tel: (650) 567-5500
Fax: (650) 567-5540
Instant Messenger: